Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Parkinson's Disease,Idiopathic”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Very early researchEnded earlyNCT02393027
What this trial is testing

Quantification of Dopamine Active Transporter (DAT) in Humans: Validation of a New Radiophamaceutical, the [18F] LBT-999

Who this might be right for
Idiopathic Parkinson Disease
University Hospital, Tours 16
Not applicableLooking for participantsNCT06705517
What this trial is testing

Mediterranean Diet Effects on Parkinson's Disease

Who this might be right for
ParkinsonParkinson DiseaseParkinson Disease, Idiopathic+1 more
Università degli Studi dell'Insubria 44
Not applicableStudy completedNCT04002596
What this trial is testing

Safety and Initial Effectiveness of Transcranial MR Guided Focused Ultrasound for the Treatment of Parkinson's Disease

Who this might be right for
Parkinson Disease
InSightec 26
Early research (Phase 1)UnknownNCT05691114
What this trial is testing

Precise Transplantation of Human Amniotic Epithelial Stem Cells Into Lateral Ventricle for Parkinson's Disease

Who this might be right for
Idiopathic Parkinson's Disease
Shanghai East Hospital 18
Large-scale testing (Phase 3)Study completedNCT02242487
What this trial is testing

Twelve Month Safety and Efficacy Study of CVT-301 In Parkinson's Disease Patients With OFF Episodes

Who this might be right for
Idiopathic Parkinson's Disease
Acorda Therapeutics 325
Post-approval studies (Phase 4)Study completedNCT00141518
What this trial is testing

Long-term Study of Duodopa (Levodopa/Carbidopa) in Advanced Parkinson's: Health Outcomes & Net Economic Impact

Who this might be right for
Advanced Idiopathic Parkinson's Disease
AbbVie (prior sponsor, Abbott) 77
Not applicableStudy completedNCT01807338
What this trial is testing

A Follow-up Study on Safety and Tolerability of Intracerebroventricular Administration of sNN0031 to Patients With Parkinson's Disease

Who this might be right for
Parkinson's Disease
Newron Sweden AB 11
Not applicableEnded earlyNCT00663312
What this trial is testing

Impact of Deep Brain Stimulation of Subthalamic Nucleus on the Hepatic Glucose Production in Parkinson's Disease

Who this might be right for
Idiopathic Parkinson's Disease
University Hospital, Clermont-Ferrand 8
Not applicableUnknownNCT01005030
What this trial is testing

Spectroscopy in Parkinson Disease

Who this might be right for
Parkinson Disease
Molecular Biometrics, Inc. 500
Not applicableStudy completedNCT02231294
What this trial is testing

The Effect of Sifrol® on Tremor and Depression in Patients With Idiopathic Parkinson's Disease

Who this might be right for
Parkinson Disease
Boehringer Ingelheim 1,464
Not applicableStudy completedNCT03645226
What this trial is testing

Gut Microbiota Across Early Stages of Synucleinopathy: From High-risk Relatives, REM Sleep Behavior Disorder to Early Parkinson's Disease

Who this might be right for
REM Sleep Behavior Disorder
Chinese University of Hong Kong 441
Testing effectiveness (Phase 2)Study completedNCT05699161
What this trial is testing

Adipose-derived Stromal Vascular Fraction Cells to Treat Parkinson

Who this might be right for
Idiopathic Parkinson DiseaseParkinson's Disease and Parkinsonism
Samuel Vilchez, PhD 10
Early research (Phase 1)Study completedNCT06659562
What this trial is testing

Clinical Study of HER-096 in Healthy Volunteer Subjects and Patients With Parkinson's Disease

Who this might be right for
Parkinson Disease, Idiopathic
Herantis Pharma Plc. 32
Post-approval studies (Phase 4)Ended earlyNCT01519882
What this trial is testing

Sleep Efficiency Assessed by Polysomnography (PSG Sleep Lab Testing) in Advanced Parkinson's Disease

Who this might be right for
Advanced Idiopathic Parkinson's Disease
UCB Pharma SA 1
Large-scale testing (Phase 3)Study completedNCT02352363
What this trial is testing

Randomized Safety Study of CVT-301 Compared to an Observational Control Group

Who this might be right for
Idiopathic Parkinson's Disease
Acorda Therapeutics 408
Large-scale testing (Phase 3)Study completedNCT00642889
What this trial is testing

Safinamide as Add-On Therapy in Patients With Early Idiopathic Parkinson's Disease Treated With a Stable Dose of a Single Dopamine Agonist (12 Month Extension)

Who this might be right for
Parkinson's Disease
Newron Pharmaceuticals SPA 227
Not applicableStudy completedNCT01931644
What this trial is testing

At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions

Who this might be right for
All Diagnosed Health ConditionsADD/ADHDAlopecia Areata+58 more
Sanguine Biosciences 17,667
Testing effectiveness (Phase 2)Study completedNCT00866502
What this trial is testing

A Safety and Tolerability Study of Intracerebroventricular Administration of sNN0031 to Patients With Parkinson's Disease

Who this might be right for
Parkinson's Disease
Newron Sweden AB 12
Large-scale testing (Phase 3)Study completedNCT03881371
What this trial is testing

Evaluate the Efficacy and Safety of Safinamide, as add-on Therapy, in Idiopathic Chinese Parkinson's Disease (PD) Patients With Motor Fluctuations Treated With Stable Doses of Levodopa

Who this might be right for
Parkinson Disease
Zambon SpA 307
Testing effectiveness (Phase 2)Study completedNCT01777555
What this trial is testing

Efficacy and Safety Study of Inhaled CVT 301 in Parkinson's Disease Patients for Treatment of OFF Episodes

Who this might be right for
Idiopathic Parkinson's Disease
Acorda Therapeutics 89
Next Page